KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Minority Interest: 2018-2021

Historic Minority Interest for Guardant Health (GH) over the last 3 years, with Sep 2021 value amounting to $59.4 million.

  • Guardant Health's Minority Interest rose 5.32% to $59.4 million in Q3 2021 from the same period last year, while for Sep 2021 it was $59.4 million, marking a year-over-year increase of 5.32%. This contributed to the annual value of $57.1 million for FY2020, which is 15.12% up from last year.
  • Per Guardant Health's latest filing, its Minority Interest stood at $59.4 million for Q3 2021, which was down 0.00% from $59.4 million recorded in Q2 2021.
  • Guardant Health's Minority Interest's 5-year high stood at $59.4 million during Q1 2021, with a 5-year trough of $41.8 million in Q4 2018.
  • For the 3-year period, Guardant Health's Minority Interest averaged around $52.5 million, with its median value being $50.4 million (2020).
  • Its Minority Interest has fluctuated over the past 5 years, first fell by 2.15% in 2020, then skyrocketed by 30.55% in 2021.
  • Quarterly analysis of 4 years shows Guardant Health's Minority Interest stood at $41.8 million in 2018, then grew by 18.66% to $49.6 million in 2019, then increased by 15.12% to $57.1 million in 2020, then rose by 5.32% to $59.4 million in 2021.
  • Its last three reported values are $59.4 million in Q3 2021, $59.4 million for Q2 2021, and $59.4 million during Q1 2021.